[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334050-105":59,"doc-detail-334050-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","fkbp4-promotes-glycolysis-and-hepatocellular-carcinoma-progression-via-p53hk2-axis","FKBP4 promotes glycolysis and hepatocellular carcinoma progression via p53/HK2 axis","","FKBP4, an FK506-binding protein family member, is investigated as a potential target in hepatocellular carcinoma (HCC). Bioinformatics analyses of TCGA LIHC, ICGC LIRI-JP, and GEO datasets show FKBP4 upregulation in HCC tissues, confirmed by elevated expression in clinical samples and high levels across five tested HCC cell lines. Increased FKBP4 correlates with poor patient prognosis, while FKBP4 loss suppresses proliferation, migration, glucose uptake, lactic acid production, and 18F-FDG uptake.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/fkbp4-promotes-glycolysis-and-hepatocellular-carcinoma-progression-via-p53hk2-axis/334050/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/fkbp4-promotes-glycolysis-and-hepatocellular-carcinoma-progression-via-p53hk2-axis/334050.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How is FKBP4 related to hepatocellular carcinoma progression?","Question",{"text":113,"@type":114},"FKBP4 is upregulated in HCC tissues and its elevated expression is linked to poor prognosis. Functionally, FKBP4 loss inhibits HCC cell proliferation and migration.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What metabolic changes are affected by FKBP4 knockdown?",{"text":118,"@type":114},"Silencing FKBP4 suppresses glucose uptake, lactic acid production, and 18F-FDG uptake compared with control cells.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism connects FKBP4 to glycolysis in HCC?",{"text":122,"@type":114},"FKBP4 regulates glycolysis through a p53-mediated HK2 signaling pathway. FKBP4 knockdown promotes p53 protein expression and stability, and combined knockdown of FKBP4 and p53 partially reverses the decreases in HK2 protein and 18F-FDG uptake.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334050,1790013126,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nFKBP4 promotes glycolysis and hepatocellular carcinoma progression via p53/HK2 axis  \nZhenzhen Zeng1,2, Shasha Xu1,2, Ruihua Wang1,2􀀍 & Xingmin Han1,2􀀍  \nFKBP4, a member of the FK506-binding protein (FKBP) family, is a promising target for a variety of disorders, including cancer. However, its underlying molecular mechanism and potential function in hepatocellular carcinoma (HCC) are largely elusive. Therefore, we aimed to investigate the expression status, functional implications and underlying mechanisms of FKBP4 in HCC. Our bioinformatics analysis of TCGA LIHC datasets, ICGC LIRI-JP datasets and GEO datasets results showed FKBP4 was upregulated in HCC tissues. We also confirmed the elevated FKBP4 in clinical HCC samples. Additionally, quantitative RT-PCR results revealed FKBP4 was highly expressed in all five tested HCC cell lines. We also observed a correlation between elevated FKBP4 expression and poor prognosis in HCC patients. Loss of FKBP4 can inhibit the proliferation and migration in HCC cells. Furthermore, we found that silencing FKBP4 suppressed glucose uptake, lactic acid production and 18F-FDG uptake compared with the control group. Mechanistically, our funding indicated that FKBP4 participates in glycolysis through p53 mediated HK2 signaling pathway, specially, FKBP4 knockdown promotes the expression and stability of p53 protein rather than affecting the transcription level. Finally, rescue experiments revealed that simultaneous knockdown of both FKBP4 and p53 partially reversed the inhibitory effects on HK2 protein levels and 18F-FDG uptake. Our study elucidates a novel role of FKBP4 in promoting HCC development and glycolysis by modulating the p53/HK2 signaling pathway. Given the critical role of aerobic glycolysis in the progression of HCC, targeting FKBP4 may offer a new therapeutic strategy for treating this malignancy.  \nHepatocellular carcinoma (HCC) is one of the most common cancers and the third leading cause of cancerrelated death worldwide1. Hepatocarcinogenesis was a complicated process involving multiple factors that contribute to the initiation, development, and progression of HCC2. At present, the primary therapeutic agents for advanced HCC include multi-kinase inhibitors and immune checkpoint inhibitors. Unfortunately, the clinical benefit of oral inhibitors is limited3. Despite advancements in early diagnosis and specialized treatments for HCC, patients still suffer from poor prognosis and high recurrence rate, with median survival ranging from 6 to 20 months4. Due to liver dysfunction or metastasis, many patients lose surgical intervention opportunities. The molecular mechanism of HCC remains largely undefined, therefore, it is crucial to elucidate novel molecular mechanism and identify new therapeutic target for HCC.  \nFK506-binding proteins (FKBPs), intracellular receptors that binding FK506, belong to the immunophilin family and have been implicated in various biological pathways related to embryology, stress reaction, cardiac and neuronal function, indicating that they may play important roles in occurrence and development of different diseases including cancers. FKBP4, also known as FKBP52, is a high-molecular-weight immunophilins characterized C-terminal tetratricopeptide repeat (TPR) domains that can form complexes with the molecular chaperone Hsp90, and participate in protein-protein interactions. Evidence indicates that FKBP4 exerts relevant effects on various cancer cell types. For instance, in breast cancer models, especially in estrogen receptor (ER) -negative breast cancer, high expression of FKBP4 potentiate PI3K-Akt-mTOR signaling to facilitate tumor proliferation and survival5. Additionally, in Alzheimer’s disease (AD) brain neurons, the abnormal FKBP4 decrease could hinder autophagy efficiency and contribute to the progression of the tauopathy by modulating microtubule associated protein tau (MAPT) ","cbCait6L5dkIjZ9B","https://ap.wps.com/l/cbCait6L5dkIjZ9B","pdf",7150174,13,"English","# Background and Rationale\n## Existing therapies and unmet clinical need in HCC\n# FKBP4 in HCC: expression and clinical relevance\n## Upregulation in datasets and patient samples\n## Association with prognosis and functional impact\n# Metabolic mechanism: glycolysis regulation\n## Effects on glucose uptake, lactate production, and 18F-FDG\n## p53-mediated HK2 signaling pathway\n# Rescue experiments and therapeutic implications\n## Reversal by combined FKBP4 and p53 knockdown","[{\"question\":\"How is FKBP4 related to hepatocellular carcinoma progression?\",\"answer\":\"FKBP4 is upregulated in HCC tissues and its elevated expression is linked to poor prognosis. Functionally, FKBP4 loss inhibits HCC cell proliferation and migration.\"},{\"question\":\"What metabolic changes are affected by FKBP4 knockdown?\",\"answer\":\"Silencing FKBP4 suppresses glucose uptake, lactic acid production, and 18F-FDG uptake compared with control cells.\"},{\"question\":\"What mechanism connects FKBP4 to glycolysis in HCC?\",\"answer\":\"FKBP4 regulates glycolysis through a p53-mediated HK2 signaling pathway. FKBP4 knockdown promotes p53 protein expression and stability, and combined knockdown of FKBP4 and p53 partially reverses the decreases in HK2 protein and 18F-FDG uptake.\"}]","FKBP4 promotes glycolysis and hepatocellular carcinoma progression via p53/HK2 axis | PDF",1790005134,33]